Arvate, H.R. 2025. Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review. International Journal of Nutrology. 18, 1 (Jan. 2025). DOI:https://doi.org/10.54448/ijn25102.